Table 1 Demographics of stage IV IBC patients

Patient 1

42

H

ER⁻PR⁻Her2⁺

Month 18

Treated

67 months

Patient 2

47

C

TN

Secondary IBC

Month 12

Treated

27 months

Patient 3

55

C

TN

Month 20

Treated

38 months

Patient 5

49

C

ER⁻PR⁻Her2⁺

Month 30

Treated

44 months*

Patient 6

66

C (J)

ER⁺PR⁻Her2⁻ (became TN at month 8)

Month 8

Treated

10 months (cardiac disease)

Patient 7

48

C

TN

Month 21

Treated

27 months

Patient 8

32

C

ER⁺PR⁻Her2⁻

Month 50

Treated

105 months

Patient 9

55

A

ER⁻PR⁻Her2⁺

Month 4

Treatment naive

16 months

Patient 10

62

C

TN

Month 32

Treated

37 months

Patient 11

61

C

TN

Month 13

Treated

31 months

Patient 13

43

C

ER⁺PR⁺Her2⁺

Month 1

Treatment naive

87 months

Patient 14^†

44

C

ER⁻PR⁻Her2⁺

Month 13

Treated

115 months

Patient 15

30

C

ER⁺PR⁻Her2⁺

Month 22

Treated

39 months

Patient 16

69

A

ER⁻PR⁻Her2⁺

Month 26

Treated

37 months